|
Unique Patients
|
|
Chemotherapy
|
Medical outpatient 1/1/2017–5/31/2018
|
218 716
|
|
No chemotherapy 5 years prior
|
122 112 |
|
Pegfilgrastim
|
Pegfilgrastim 1/1/2017–5/31/2018 (index date)
|
26 283 |
|
Join
|
Chemotherapy and pegfilgrastim ≤5 days apart
|
12 880 |
|
Enrollment
|
6 months prior to index date
|
9854 |
|
6 months following index date
|
8001 |
|
Adult
|
Adult on index year
|
7968 |
|
Cancer
|
≥1 diagnosis of cancer prior to index date
|
5667 |
|
Exclusion
|
Myeloid cancer
|
5642 |
|
Pregnancy
|
5539 |
|
Clinical trial participation
|
5427 |
|
HIV positive
|
5408 |
|
Hematopoietic cell transplantation
|
5385 |
|
Other types of non-myeloid cancers
|
4849 |
|
Missing region
|
4840 |
|
Final total
|
4460 |